SCHEMBL1032609

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL1032643	0.92	RXFP1 (0.44)	PLGPLAUPLATCA2CA9
	SCHEMBL1032642	0.92	RXFP1 (0.44)	PLGPLAUPLATCA2CA9
	SCHEMBL1035575	0.92	RXFP1 (0.44)	PLGPLAUPLATCA2CA9
	SCHEMBL13627127	0.91	PLG (0.45)	PLGPLAUPLATEGLN1CA2
	SCHEMBL17772307	0.89	PLG (0.44)	PLGPLAUPLATEGLN1CA2
	SCHEMBL1035301	0.89	ABL1 (0.47)	ABL1
	SCHEMBL13187587	0.83	PLG (0.46)	PLGPLAUPLATEGLN1KDR
	SCHEMBL1034121	0.82	P2RX1 (0.43)	ABL1
	SCHEMBL1034065	0.81	RXFP1 (0.53)	CA2CA9CA12CA1RXFP1
	SCHEMBL1034692	0.81	TP53 (0.47)	PLGPLAUPLATKITRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.